(Q48535643)

English

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

scientific article published on 18 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

type 2 diabetes

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

Christopher J. Weir

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

Joanne R. Morling

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

9

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

10

object named as

Jackie F Price

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

Stela McLachlan

7

object named as

Stela McLachlan

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

4

object named as

Insa Feinkohl

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

author name string

Anna H Price

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

Christine M Robertson

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

Mark W J Strachan

8

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

publication date

18 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

57

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

12

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

2505-2512

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

https://scigraph.springernature.com/pub.10.1007/s00125-014-3375-9

0 references

C-reactive protein, fibrinogen, and cardiovascular disease prediction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

The Edinburgh Type 2 Diabetes Study: study protocol

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3375-9

21 January 2018

NT-proBNP and cardiac events in older diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25231020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-014-3375-9

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/25231020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48535643&oldid=2201398239"